Immunoforge Co. Ltd.’s approval of an IND by the Korea Ministry of Food and Drug Safety reminded Wall Street – not that anybody needed reminding – about the marketplace jostle among therapies for ...

Jan. 14 (UPI) --The U.S. Food and Drug Administration hopes "front-of-package" labeling will better improve the American population's health, the FDA announced. "Food should be a vehicle for ...

Tyrosine kinase inhibitors (TKIs) are already available, such as the Novartis drugs Scemblix and Gleevec. But CML can become resistant to these therapies, Ascentage said in its IPO filing.

It’s in multi-country Phase 3 trials in CML, as well as for two other forms of cancer. Though similar drugs, such as Novartis’ Gleevec and Scemblix, are available, there is room for improvement, as ...

If you book a package holiday, you have rights under the Package Travel Regulations. This means descriptions of holidays must be accurate. Our guides help you claim if you’re unhappy with your holiday ...

One study conducted in Thailand compared the effectiveness of PILs to traditional package inserts (PIs) in enhancing patients' medication safety knowledge. The findings revealed that patients who ...

Ad hoc announcement pursuant to Art. 53 LR The Phase III STEER study met its primary endpoint showing an increase from baseline in HFMSE total score in patients with SMA treated with intrathecal ...

Myeloproliferative neoplasms are blood cancers that affect myeloid stem cells. Treatment can involve targeted medications or careful monitoring. Myeloproliferative disorders are a group of cancers ...

One of the best ways to improve the customer’s shopping experience is with package inserts; customer package inserts can be designed to improve the customer’s unpackaging experience greatly, which in ...

This package contains a PackageServiceProvider that you can use in your packages to easily register config files, migrations, and more. Here's an example of how it can be used. We invest a lot of ...

Patients with this mutation may be treated with Ponatinib (brand name: Iclusig) or Asciminib (brand name: Scemblix) and are generally encouraged to consider transplantation. Scemblix® (asciminib) and ...